Porsolt expands laboratories and links up with Argenta
This article was originally published in Scrip
Executive Summary
The French preclinical CRO Porsolt & Partners Pharmacology has started building a new 60,000ft2 laboratory facility near its site in Laval, France, which is expected to be completed early next year.